Artificial nucleic acid molecules encoding a norovirus antigen and uses thereof
AssigneeCureVac AG
InventorsSusanne Rauch, Kim Ellen Schwendt, Benjamin Petsch
Life of this patent
Estimating the term…
Loading patent…
AssigneeCureVac AG
InventorsSusanne Rauch, Kim Ellen Schwendt, Benjamin Petsch
Estimating the term…
The present invention is directed to an artificial nucleic acid and to polypeptides suitable for use in treatment or prophylaxis of an infection with Norovirus or a disorder related to such an infection. In particular, the present invention concerns a Norovirus vaccine. The present invention is directed to an artificial nucleic acid, polypeptides, compositions and vaccines comprising the artificial nucleic acid or the polypeptides. The invention further concerns a method of treating or preventing a disorder or a disease, first and second medical uses of the artificial nucleic acid, polypeptides, compositions and vaccines. Further, the invention is directed to a kit, particularly to a kit of parts, comprising the artificial nucleic acid, polypeptides, compositions and vaccines.
Artificial nucleic acid molecule comprising at least one coding region encoding a Norovirus VP1 polypeptide, said coding region having at least 90% identity to a sequence of SEQ ID NOs:
Dependencies are inferred from the claim text.